NATALIE ST CLAIR: Open Payments
NPI 1326758467 · WICHITA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$449 in 20 payments from 11 companies in 2025. Trend: 2023 $948 · 2024 $436 · 2025 $449
Food & beverage: $449
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $96 |
| Otsuka America Pharmaceutical, Inc. | 4 | $72 |
| Teva Pharmaceuticals USA, Inc. | 3 | $47 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $46 |
| Corium, LLC | 2 | $42 |
| Vanda Pharmaceuticals Inc. | 1 | $37 |
| Alkermes, Inc. | 2 | $28 |
| Lundbeck LLC | 1 | $27 |
| Supernus Pharmaceuticals, Inc. | 1 | $20 |
| Axsome Therapeutics, Inc. | 1 | $19 |
Products named: REXULTI, COBENFY, CAPLYTA, Azstarys, HETLIOZ, AUSTEDO XR, ARISTADA, Qelbree.
Industry payments across KS — which companies pay providers there.
